Editor’s Comment: The FDA has instituted a “black box” label warning for antidepressants, indicating that antidepressants may increase the risk of suicidal thinking and behavior in some children and adolescents. A black-box warning is the most serious type of warning in prescription drug labeling. Cognitive behavioral therapy, the second treatment recommended in this study, has been widely contested as “ineffective, not evidence-based, and potentially harmful for CFS treatment." (Twisk and Maes, 2009. “ A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.” Neuro Endocrinol. Lett. 30, 284–299.)
The full article can be read HERE.
Neurocognitive impairment in childhood chronic fatigue syndrome.
By K. Mizuno
Neurocognitive impairment is a feature of childhood chronic fatigue syndrome (CCFS). Several studies have demonstrated reduced attention control in CCFS patients in switching and divided attention tasks.
In students, the extent of deterioration in task performance depends on the level of fatigue. Poor performance in switching and divided attention is common in both fatigued students and CCFS patients. Additionally, attentional functions show dramatic development from childhood to adolescence, suggesting that abnormal development of switching and divided attention may be induced by chronic fatigue.
The brain structures associated with attentional control are situated in the frontal and parietal cortices, which are the last to mature, suggesting that severe fatigue in CCFS patients and students may inhibit normal structural and functional development in these regions.
A combination of treatment with cognitive behavioral therapy and antidepressant medication is effective to improve attentional control processing in CCFS patients. Studies identifying the features of neurocognitive impairment in CCFS have improved our current understanding of the neurophysiological mechanisms of CCFS.
Source: Front Physiol. 2013 Apr 19;4:87. doi: 10.3389/fphys.2013.00087. Print 2013. Mizuno K, Watanabe Y. Pathophysiological and Health Science Team, RIKEN Center for Life Science Technologies Kobe City, Hyogo, Japan ; Department of Physiology, Osaka City University Graduate School of Medicine Osaka, Japan ; Department of Medical Science on Fatigue, Osaka City University Graduate School of Medicine Osaka, Japan.